AROC vs EW · P/E 21, rev $1.16B vs P/E 47, rev $1.39B
Archrock Inc (AROC) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Archrock Inc (AROC) is a oil & gas equipment & services company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported AROC revenue for 2024-12-31 was $1.16B. Net income was $172.2M. Revenue was up 16.9% from 2023-12-31 to 2024-12-31. AROC currently screens at market cap $4.37B and trailing P/E 20.8.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
AROC currently screens at market cap $4.37B and trailing P/E 20.8. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the AROC and EW stock pages for the full models.
Not investment advice.